|
| << vorige | volgende >> |
Tijdschrift beschrijving
Alle jaargangen van het bijbehorende tijdschrift
Alle afleveringen van het bijbehorende jaargang
Alle artikelen van de bijbehorende aflevering
Details van artikel 12 van 18 gevonden artikelen
| Titel: |
Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic renal cell carcinoma treated with first-line and subsequent second-line targeted therapy: A proposal of the modified-IMDC risk model 1 1 Dr. Mizuno reports grants from The Japan Agency for Medical Research and Development (AMED), personal fees from Pfizer, grants and personal fees from Novartis, during the conduct of the study. Dr. Mikami reports grants from The Japan Agency for Medical Research and Development (AMED) during the conduct of the study. Dr. Oya reports grants from The Japan Agency for Medical Research and Development (AMED), grants and personal fees from Pfizer, grants and personal fees from Novartis, personal fees from Bayer, during the conduct of the study. No potential conflicts of interest were disclosed by the other authors. |
| Auteur: |
Tanaka, Nobuyuki Mizuno, Ryuichi Yasumizu, Yota Ito, Keiichi Shirotake, Suguru Masunaga, Ayako Ito, Yujiro Miyazaki, Yasumasa Hagiwara, Masayuki Kanao, Kent Mikami, Shuji Nakagawa, Ken Momma, Tetsuo Masuda, Takeshi Asano, Tomohiko Oyama, Masafumi Oya, Mototsugu |
| Verschenen in: |
Urologic oncology |
| Paginering: | Jaargang 35 (2017) nr. 2 pagina's 3.8999999961E29 p. |
| Jaar: |
2017 |
| Inhoud: | |
| Uitgever: |
Elsevier Inc. |
| Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
Details van artikel 12 van 18 gevonden artikelen
| << vorige | volgende >> |